UTHR-a Promising Biotech in the works here? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : UTHR-a Promising Biotech in the works here?

UTHR 445.43

-1.8%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kendall harmon who wrote ()	8/24/1999 7:24:00 PM
From: kendall harmon	of 66

UTHR--confirmation of Dr. Rich's paper on UT-15, their lead product, next Tuesday Day: Tuesday, August 31, 1999 Time: 08:30 Room: Palau de Congressos F Type: Abstract session Title: Pulmonary hypertension: new pharmacologic approaches Chairpersons: N. Galie (Bologna, IT), J. Widimsky (Prague, CZ) Time: 08:45 Program number: 2555 Title: Efficacy and safety of UT-15, a prostacyclin analogue, for primary pulmonary hypertension. Speakers: V. McLaughlin; R. Barst; S. Rich; L. Rubin; E. Horn; S. Gaine; S. Blackburn; J. Crow Affiliation: Chicago IL and Research Triangle Park NC, US Source:http://ex2.excerptamedica.com/99esc/

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next